Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Anticoagulants industry 360º synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Drug category trends
2.1.4 Route of administration trends
2.1.5 Application trends
2.1.6 Distribution channel trends
Chapter 3 Anticoagulants Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing prevalence of chronic disease
3.2.1.2 Growing adoption of novel oral anticoagulants (NOACs)
3.2.1.3 Rising geriatric population across the globe
3.2.2 Industry pitfalls & challenges
3.2.2.1 High risk of side effects
3.2.2.2 Stringent regulatory framework
3.3 Growth potential analysis
3.3.1 By drug category
3.3.2 By route of administration
3.3.3 By application
3.3.4 By distribution channel
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Anticoagulants Market Size and Forecast, By Drug Category (USD Million)
5.1 Key trends, by drug category
5.2 Factor Xa inhibitor
5.3 Heparin
5.4 Warfarin
5.5 Direct thrombin inhibitor
5.6 Others
Chapter 6 Anticoagulants Market Size and Forecast, By Route of Administration (USD Million)
6.1 Key trends, by route of administration
6.2 Oral
6.3 Injectable
Chapter 7 Anticoagulants Market Size and Forecast, By Application (USD Million)
7.1 Key trends, by application
7.2 Venous thromboembolism
7.3 Atrial fibrillation/flutter
7.4 Coronary artery disease
7.5 Others
Chapter 8 Anticoagulants Market Size and Forecast, By Distribution Channel (USD Million)
8.1 Key trends, by distribution channel
8.2 Hospital pharmacy
8.3 Retail pharmacy
8.4 Online pharmacy
Chapter 9 Anticoagulants Market Size and Forecast, By Region (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Bristol-Myers Squibb Company
10.2 Bayer AG
10.3 Boehringer Ingelheim
10.4 Johnson and Johnson
10.5 Daiichi Sankyo Company
10.6 Amphastar Pharmaceuticals, Inc.
10.7 Leo pharma
10.8 Pfizer
10.9 ROVI
10.10 Sanofi
10.11 Shenzhen Hepalink
10.12 United Therapeutics
